Addiction and Behavior Related to Menthol Cigarette Substitutes

NCT ID: NCT04844762

Last Updated: 2024-02-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-16

Study Completion Date

2021-08-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the proposed study is to examine the abuse liability and substitutability of plausible menthol cigarette alternatives currently on the market, including menthol filtered little cigars (mFLC), menthol roll-your-own (mRYO) pipe tobacco and cigarette tubes, and non-menthol cigarettes (nmC). In addition, the study will elucidate real-time mechanisms including product characteristics and perceived effects associated with greater substitution.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using an in-laboratory and ad libitum outpatient mixed design, 80 current menthol cigarette smokers will complete a three phase, 3 week study: in Phase 1, utilizing a randomized crossover design, participants will complete 5 smoking sessions, each session smoking a different product examining each participants puff topography while sampling the product, the products' ability to suppress nicotine craving/withdrawal, and the product's demand indices. Products will include participants usual brand menthol cigarette (UBMC) as well as 3 commercially-available alternatives, including an mFLC, a pre-assembled mRYO product (menthol tobacco and non-menthol tube), and an nmC. All sessions will occur following 12 hours of nicotine abstinence and be separated by 48 hours. In Phase 2, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their UBMC for one week. Participants will complete ecological momentary assessments (EMA) during this period to more accurately assess degree of substitution and perceived effects in real time. In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product, under simulated ban conditions using a progressive ratio task. In all phases, multiple domains of abuse liability will be assessed, including product administration (in-lab puff topography and EMA self-report measures), product liking and craving and withdrawal suppression (in-lab and EMA self-report), and a hypothetical purchase task to simulate demand.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking (Tobacco) Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

usual brand menthol cigarette (UBMC)

Study participant's usual brand menthol cigarette

Group Type ACTIVE_COMPARATOR

Menthol cigarettes substitutes

Intervention Type BEHAVIORAL

In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.

Menthol cigarettes substitutes and menthol cigarettes

Intervention Type BEHAVIORAL

In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.

menthol roll-your-own cigarette (mRYO)

Mentholated pipe tobacco in a roll-your-own cigarette tube

Group Type ACTIVE_COMPARATOR

Menthol cigarettes substitutes

Intervention Type BEHAVIORAL

In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.

Usual brand menthol cigarettes and substitutes

Intervention Type BEHAVIORAL

In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.

Menthol cigarettes substitutes and menthol cigarettes

Intervention Type BEHAVIORAL

In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.

menthol filtered little cigar (mFLC)

The menthol filtered cigar will be Cheyenne (Cheyennecigars.com) Seneca (senecacigars.com)

Group Type ACTIVE_COMPARATOR

Menthol cigarettes substitutes

Intervention Type BEHAVIORAL

In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.

Usual brand menthol cigarettes and substitutes

Intervention Type BEHAVIORAL

In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.

Menthol cigarettes substitutes and menthol cigarettes

Intervention Type BEHAVIORAL

In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.

non-menthol cigarette (nmC)

The non-menthol cigarette will be Newport non-menthol cigarettes.

Group Type ACTIVE_COMPARATOR

Menthol cigarettes substitutes

Intervention Type BEHAVIORAL

In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.

Usual brand menthol cigarettes and substitutes

Intervention Type BEHAVIORAL

In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.

Menthol cigarettes substitutes and menthol cigarettes

Intervention Type BEHAVIORAL

In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Menthol cigarettes substitutes

In Phase 1, participants will complete 4 smoking sessions using a different product each session to examine each product's abuse liability.

Intervention Type BEHAVIORAL

Usual brand menthol cigarettes and substitutes

In Phase 2, to assess uptake, changes in subjective effects, and use over time, participants will select their preferred study product from Phase 1 and be instructed to completely substitute the product for their usual brand menthol cigarette for one week.

Intervention Type BEHAVIORAL

Menthol cigarettes substitutes and menthol cigarettes

In Phase 3, participants will complete a final in-lab visit to assess the substitutability of their preferred product from Phases 1 and 2, under simulated ban conditions using a progressive ratio task.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* current menthol cigarette smoker (\>90% menthol cigarette use; ≥5 cigarettes per day) for at least the past 6 months.
* between 18-24 (young adult) or 25-50 years old (aged 25+)
* willing to provide informed consent and abstain from all tobacco and nicotine use for at least 12 hours prior to the five lab sessions
* willing to complete one week of EMA
* read and speak English.

Exclusion Criteria

* self-reported diagnosis of lung disease including asthma, cystic fibrosis, or chronic obstructive pulmonary disease
* unstable or significant psychiatric conditions (past and stable conditions will be allowed)
* history of cardiac event or distress within the past 3 months
* currently pregnant, planning to become pregnant, or breastfeeding (will be verified with urine pregnancy test)
* use of other tobacco products (e.g., e-cig, cigar, etc.) \>5 days in the past month
* current marijuana use \>5 times per month
* any use of other illicit drugs during the last 30 days (verified by urinalysis at initial visit)
* currently engaging in a smoking cessation attempt
* currently using one of the alternative menthol study products
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Vermont

OTHER

Sponsor Role collaborator

Brown University

OTHER

Sponsor Role collaborator

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

Ohio State University Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Theodore Wagener

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Theodore Wagener, PhD

Role: PRINCIPAL_INVESTIGATOR

Ohio State University Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Villanti AC, Hinton A, Schulz JA, Erath TG, Mehta T, Reed D, Tidey J, Businelle M, Wagener TL. Substitutability of menthol cigarette alternatives: a clinical trial. Tob Control. 2025 Apr 1;34(2):154-161. doi: 10.1136/tc-2023-058272.

Reference Type DERIVED
PMID: 37963771 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R21DA046333-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

OSU-19145

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

De-nicotinised Cigarettes Study
NCT01250301 COMPLETED NA
Smoking Cessation in Alcoholism Treatment
NCT00000454 COMPLETED PHASE4
Cannabis and Tobacco Co-use Study
NCT04228965 COMPLETED PHASE4